Medicare Enrolled
Dr. Kevin Gordon, M.D.
Student in an Organized Health Care Education/Training Program · Wyomissing, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gordon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gordon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gordon
Dr. Kevin Gordon is a student in an organized health care education/training program specialist in Wyomissing, PA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Gordon performed 5,252 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gordon received a total of $2,846 from 27 pharmaceutical and/or device companies across 172 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gordon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 2% volume in PA
$2,846 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,252
Medicare services
Top 2% in PA for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
4,500 | $17 | $57 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
115 | $84 | $645 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
113 | $203 | $1,025 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
103 | $92 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $66 | $185 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
59 | $100 | $240 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $61 | $120 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
37 | $38 | $85 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
32 | $175 | $750 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $113 | $410 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
25 | $97 | $875 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
25 | $64 | $150 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
24 | $74 | $530 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
22 | $109 | $750 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
18 | $156 | $750 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $88 | $270 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
15 | $51 | $232 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $43 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
86.0% high complexity
4.5% medium
9.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,846
Total received (2018-2024)
Avg $407/year across 7 years
Top 11% in PA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
172
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$425
2023
$241
2022
$238
2021
$437
2020
$279
2019
$468
2018
$759
Payments by company (2024)
ABBVIE INC.
$170
Janssen Biotech, Inc.
$96
Phathom Pharmaceuticals, Inc.
$41
Digestive Care, Inc.
$34
GENZYME CORPORATION
$20
Olympus America Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
PFIZER INC.
$14
Mauna Kea Technologies, Inc.
$13
Top 3 companies account for 72.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$471
ABBVIE INC.
$317
AbbVie, Inc.
$233
Gilead Sciences, Inc.
$221
CapsoPro Services LLC
$200
Takeda Pharmaceuticals U.S.A., Inc.
$178
PFIZER INC.
$167
AbbVie Inc.
$166
Celgene Corporation
$165
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$163
Synergy Pharmaceuticals Inc
$141
BOSTON SCIENTIFIC CORPORATION
$64
Phathom Pharmaceuticals, Inc.
$41
GENZYME CORPORATION
$37
Intercept Pharmaceuticals, Inc.
$37
Digestive Care, Inc.
$34
Evoke Pharma, Inc.
$31
Nestle HealthCare Nutrition Inc.
$27
NESTLE HEALTHCARE NUTRITION INC.
$25
Daiichi Sankyo Inc.
$23
Olympus America Inc.
$19
QOL Medical, LLC
$17
Ironwood Pharmaceuticals, Inc
$17
Shionogi Inc
$13
Merck Sharp & Dohme LLC
$13
Prometheus Laboratories Inc.
$13
Mauna Kea Technologies, Inc.
$13
Top 3 companies account for 35.9% of all-time payments
Associated products mentioned in payments ›
Amitiza · CAPTIVATOR COLD · CREON · DIFICID · DUPIXENT · Dexilant · ENTYVIO · EndoClot PHS · Entyvio · GATTEX · GENERAL BILIARY DEVICES · GIMOTI · HUMIRA · Humira · INJECTAFER · LINZESS · Linzess · MAVYRET · Mavyret · Mulpleta · OCALIVA · Pertzye · REMICADE · RINVOQ · SKYRIZI · STELARA · Sucraid · TREMFYA · TRULANCE · Trulance · UCERIS · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
383
County median income
$77,684
Nearest hospital to ZIP centroid (approximate)
SURGICAL INSTITUTE OF READING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gordon is a mixed practice specialist, with above-average Medicare volume (top 2% in PA), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gordon experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Gordon performed 4,500 vedolizumab infusion (entyvio) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gordon receive payments from pharmaceutical companies?
Yes. Dr. Gordon received a total of $2,846 from 27 companies across 172 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gordon's costs compare to other student in an organized health care education/training programs in Wyomissing?
Dr. Gordon's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gordon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Wyomissing
Browse student in an organized health care education/training programs in Wyomissing ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in PA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in PA
Which PA student in an organized health care education/training programs receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology